TGFB2 and central nervous system cancer: Though MCODE was able to identify genes such as TGFB2, a putative glioma tumour regulator and drug target [62], [63], they were mostly included in modules that displayed very low statistical significance (B-score close to 1), indicating a high likelihood of statistical artifacts.